Intercept Pharmaceuticals Inc Ret. on assets
What is the Ret. on assets of Intercept Pharmaceuticals Inc?
The Ret. on assets of Intercept Pharmaceuticals Inc is -12.73%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Health Care sector on NASDAQ compared to Intercept Pharmaceuticals Inc
What does Intercept Pharmaceuticals Inc do?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Companies with ret. on assets similar to Intercept Pharmaceuticals Inc
- Reconstruction Capital II has Ret. on assets of -12.78%
- KBL Merger IV has Ret. on assets of -12.76%
- Empress Royalty has Ret. on assets of -12.75%
- Vermilion has Ret. on assets of -12.75%
- Corporacion Empresarial de Materiales de Construccion, S.A has Ret. on assets of -12.74%
- The Mint has Ret. on assets of -12.74%
- Intercept Pharmaceuticals Inc has Ret. on assets of -12.73%
- Saga Plc has Ret. on assets of -12.73%
- Rambler Metals and Mining PLC has Ret. on assets of -12.72%
- Rambler Metals and Mining PLC has Ret. on assets of -12.72%
- Enviva Inc has Ret. on assets of -12.72%
- New Relic Inc has Ret. on assets of -12.72%
- Gungnir Resources has Ret. on assets of -12.72%